[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100492674":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":11,"responsibleParty":37,"collaborators":7,"id":39,"slug":7,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":7,"eligibilityCriteria":44,"healthyVolunteers":45,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":7,"overallStatus":14,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Queen Mary University of London","OTHER",null,[9],{"type":6,"name":10,"description":10,"armGroupLabels":7,"otherNames":7},"This is not an interventional study",[12,31],{"facility":13,"status":14,"city":15,"state":7,"zip":16,"country":17,"countryCode":18,"cosmosGeoPoint":19,"geoPoint":24,"contacts":25},"Whipps Cross University Hospital","RECRUITING","London","E11 1NR","United Kingdom","UK",{"type":20,"coordinates":21},"Point",[22,23],-0.12574,51.50853,{"lat":23,"lon":22},[26],{"name":27,"role":28,"phone":29,"phoneExt":7,"email":30},"Catherine Harwood","CONTACT","020 8539 5522","catherine.harwood1@nhs.net",{"facility":32,"status":33,"city":15,"state":7,"zip":7,"country":17,"countryCode":18,"cosmosGeoPoint":34,"geoPoint":36,"contacts":7},"Dr Emilia Peleva","ACTIVE_NOT_RECRUITING",{"type":20,"coordinates":35},[22,23],{"lat":23,"lon":22},{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100492674",false,"NCT05695222","Cutaneous Squamous Cell Carcinoma Staging Study","Comparison of the Prognostic Capacity of Existing Staging Systems for Cutaneous Squamous Cell Carcinoma","Inclusion Criteria:\n\n* Over 18 years old with diagnosis of CSCC\n\nExclusion Criteria:\n\n* Patients who decline for their data to be used for research purposes",true,"ALL","18 Years","120 Years",{"count":50,"type":51},1500,"ESTIMATED","OBSERVATIONAL","Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer, and one of the most common cancers worldwide. The majority of CSCCs are easily removed by surgery and have excellent prognosis. However, a small subset has poor outcomes, including secondary spread in the body (metastasis) and death.\n\nThe investigators will look at existing CSCC in people from two UK dermatology centres. The investigators will then evaluate the accuracy of current staging systems in predicting risk of poor outcomes in people. The investigators hope that this project will improve the management of patients with CSCC by validating the predictive power of currently available histological staging classifications for cSCC. In the second stage of the study, The investigators will see whether better prediction tools can be found.",[55],"Cutaneous Squamous Cell Carcinoma","2026-04-01",{"date":58,"type":59},"2026-04-02","ACTUAL",{"date":61,"type":59},"2023-05-01",{"date":63,"type":51},"2028-06-05",{"name":5,"class":6},2]